Industries > Pharma > Botanical and Plant-Derived Drugs Market Forecast to 2027

Botanical and Plant-Derived Drugs Market Forecast to 2027

Prospects for Leading Companies in Steroids, Phenols, Terpenes, Glycosides and Others, Sativex, Marinol Nabilone, Dexanabinol, CT-3, Cannabinor, HU 308, HU 331, Rimonabant, Taranabant

PUBLISHED: 19 December 2017
PAGES: 164
PRODUCT CODE: PHA0270

Clear
WOOCS 2.2.1

The global botanical and plant-derived drugs market is expected to grow at a CAGR of 6.8% in the first half of the forecast period. In 2016, the phenols submarket held 30.2% of the global botanical and plant-derived drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 164-page report you will receive 70 tables and 82 figures– all unavailable elsewhere.

The 164-page report provides clear detailed insight into the global botanical and plant-derived drugs market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Botanical and Plant-derived Drugs Market forecast to 2027

• This report also breaks down the revenue forecast for global botanical and plant-derived drugs market by type:
– Steroids
– Phenols
– Terpenes
– Glycosides
– Others

This report provides a SWOT analysis for each submarket.

Botanical and Plant-Derived Drugs Market Forecast to 2027

• This report also breaks down the revenue forecast for global botanical and plant-derived drugs market by application:
– Hormone Diseases
– Infectious Diseases
– Pain & Central Nervous System Disorders
– Cardiovascular & Metabolic Diseases
– Respiratory & Oncology Diseases

• Our work also shows individual revenue forecasts to 2027 for these regional and national markets
– North America: US & Canada
– Europe: Germany, France, the UK, Italy, Spain, Rest of Europe
– Asia-Pacific: China, Japan, India, Rest of APAC
– Latin America: Brazil, Mexico, Rest of Latin America
– Middle East & Africa: Saudi Arabia, South Africa, Rest of Middle East & Africa

Each regional market if further segmented by type and by application.

• This report discusses several brands, including:
– Sativex (GW Pharmaceuticals)
– Marinol (Unimed Pharmaceuticals)
– Nabilone / Cesamet (Valeant Pharmaceuticals)
– Dexanabinol (Solvay Pharmaceuticals, acquire by Abbott Laboratories)
– CT-3 (Indevus Pharmaceuticals)
– Cannabinor (Pharmos)
– HU 308 (Pharmos)
– HU 331 (Cayman Chemical)
– Rimonabant / Acomplia (Sanofi-Aventis)
– Taranabant / MK-0364 (Merck & Co.)

• This report assesses several leading companies that manufacture and market botanical and plant-derived drugs, including:
– Abbott Laboratories
– Bayer AG
– Eli Lilly
– Johnson & Johnson
– Novartis AG
– Pfizer, Inc.
– Bristol-Myers Squibb (BMS)
– Medigene AG

• This report also discusses the Drivers and Restraints of the global botanical and plat derived-drugs market.

Visiongain’s study is for everybody needing commercial analyses for the global botanical and plat derived-drugs market. You will find data, trends and predictions. Please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Botanical and Plant-Derived Drugs Market Forecast to 2027


Download sample pages

Complete the form below to download your free sample pages for Botanical and Plant-Derived Drugs Market Forecast to 2027


Latest Pharma news

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

READ

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

READ

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

READ

Visiongain Publishes Clinical Trial Supply and Logistics Market for Pharma 2021-2031

Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.

12 July 2021

READ

Categories